acut
resolv
quickli
diseas
also
fatal
mortal
rate
around
onset
sever
diseas
result
death
due
massiv
alveolar
damag
progress
respiratori
failur
share
genom
sequenc
similar
sarscov
genom
sequenc
homolog
middl
east
respiratori
syndrom
coronaviru
merscov
three
coronavirus
known
caus
sever
respiratori
symptom
liver
impair
report
patient
sar
also
report
patient
infect
merscov
least
seven
rel
largescal
case
studi
report
clinic
featur
patient
comment
assess
liver
affect
use
avail
case
studi
data
fifth
medic
center
pl
gener
hospit
beij
china
data
indic
patient
liver
comorbid
case
report
abnorm
level
alanin
aminotransferas
aspart
aminotransferas
ast
diseas
progress
tabl
patient
sever
seem
higher
rate
liver
dysfunct
studi
lancet
huang
colleagu
elev
ast
observ
eight
patient
intens
care
unit
icu
compar
seven
patient
requir
care
icu
moreov
larg
cohort
includ
patient
hospit
provinc
provinci
municip
sever
patient
diseas
abnorm
liver
aminotransferas
level
nonsever
patient
diseas
furthermor
anoth
studi
patient
diagnosi
confirm
ct
scan
subclin
phase
ie
symptom
onset
significantli
lower
incid
ast
abnorm
patient
diagnos
onset
symptom
therefor
liver
injuri
preval
sever
case
mild
case
liver
damag
patient
coronaviru
infect
might
directli
caus
viral
infect
liver
cell
approxim
patient
present
diarrhoea
rna
detect
stool
blood
sampl
evid
implic
possibl
viral
exposur
liver
sarscov
bind
angiotensinconvert
enzym
receptor
enter
target
cell
viru
replic
subsequ
infect
cell
upper
respiratori
tract
lung
tissu
patient
begin
clinic
symptom
manifest
patholog
studi
patient
sar
confirm
presenc
viru
liver
tissu
although
viral
titr
rel
low
viral
inclus
observ
patient
mer
viral
particl
detect
liver
tissu
gammaglutamyl
transferas
ggt
diagnost
biomark
cholangiocyt
injuri
report
exist
case
studi
found
elev
patient
hospitalis
centr
unpublish
also
found
elev
alkalin
phosphatas
level
observ
one
patient
hospitalis
preliminari
studi
albeit
peerreview
suggest
receptor
express
enrich
cholangiocyt
analysi
liver
tissu
patient
die
show
viral
inclus
observ
liver
also
possibl
liver
impair
due
drug
hepatotox
might
explain
larg
variat
observ
across
differ
cohort
addit
immunemedi
inflamm
cytokin
storm
pneumoniaassoci
hypoxia
might
also
contribut
liver
injuri
even
develop
liver
failur
patient
critic
ill
liver
damag
mild
case
often
transient
return
normal
without
special
treatment
howev
sever
liver
damag
occur
liver
protect
drug
usual
given
patient
unit
chronic
liver
diseas
repres
major
diseas
burden
global
liver
diseas
includ
chronic
viral
hepat
nonalcohol
fatti
liver
diseas
alcoholrel
liver
diseas
affect
approxim
million
peopl
china
given
high
burden
differ
underli
liver
condit
influenc
liver
injuri
patient
need
meticul
evalu
howev
exact
caus
preexist
liver
condit
outlin
case
studi
interact
exist
liver
diseas
studi
immun
dysfunctioninclud
lymphopenia
decreas
tcell
level
abnorm
cytokin
level
includ
cytokin
storm
common
featur
case
might
critic
factor
associ
diseas
sever
mortal
patient
chronic
hepat
b
immunotoler
phase
viral
suppress
longterm
treatment
nucleo
ide
analogu
evid
persist
liver
injuri
activ
viral
replic
coinfect
need
investig
patient
autoimmun
hepat
effect
administr
glucocorticoid
diseas
prognosi
unclear
given
express
receptor
cholangiocyt
whether
infect
aggrav
cholestasi
patient
primari
biliari
cholang
lead
increas
alkalin
phosphatas
ggt
also
need
monitor
moreov
patient
liver
cirrhosi
liver
cancer
might
suscept
infect
system
immunocompromis
statu
sever
mortal
incid
complic
patient
includ
secondari
infect
hepat
encephalopathi
upper
gastrointestin
bleed
liver
failur
need
examin
largecohort
clinic
studi
consid
immunocompromis
statu
intens
surveil
individu
tailor
therapeut
approach
need
sever
patient
outbreak
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
rapidli
spread
china
countri
govern
medic
commun
take
step
prevent
transmiss
common
sens
recommend
radic
quarantin
measur
context
time
recommend
concern
screen
donor
human
cell
tissu
cellular
tissuebas
product
releas
potenti
transmiss
transplant
yet
known
sever
institut
recommend
interim
precaut
screen
new
donor
us
food
drug
administr
suggest
consid
donor
histori
travel
area
outbreak
cohabit
infect
individu
diagnosi
suspicion
within
day
recoveri
donor
tissu
similar
measur
taken
global
allianc
eye
bank
associ
joint
unit
kingdom
blood
transfus
servic
profession
advisori
committe
rule
potenti
donor
european
societi
blood
marrow
transplant
recommend
exclud
potenti
donor
diagnos
wait
least
day
donat
histori
highrisk
travel
contact
itali
outbreak
spread
rapidli
nation
transplant
centr
taken
stronger
measur
recommend
test
potenti
tissu
stemcel
live
donor
well
dead
donor
realtim
rtpcr
assay
nasopharyng
swab
sampl
bronchoalveolar
lavag
deceas
individu
faecal
microbiota
transplant
novel
treatment
rapidli
earn
major
role
manag
recurr
clostridioid
difficil
infect
clear
advantag
antibiot
becom
increasingli
widespread
standardis
around
world
last
year
intern
expert
panel
includ
sever
author
comment
releas
recommend
screen
faecal
microbiota
transplant
donor
includ
medic
histori
blood
stool
examin
preexist
condit
advanc
liver
diseas
especi
older
patient
comorbid
research
focu
caus
liver
injuri
effect
exist
liverrel
comorbid
treatment
outcom
declar
compet
interest
